# Standard-dose Versus High-dose Flu Vaccine in Solid Organ Transplant.

> **NCT01808456** · PHASE4 · COMPLETED · sponsor: **Inova Health Care Services** · enrollment: 62 (actual)

## Conditions studied

- Influenza, Human
- Transplantation Infection

## Interventions

- **BIOLOGICAL:** influenza trivalent inactive vaccine
- **BIOLOGICAL:** influenza trivalent inactive vaccine high dose

## Key facts

- **NCT ID:** NCT01808456
- **Lead sponsor:** Inova Health Care Services
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2022-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01808456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01808456, "Standard-dose Versus High-dose Flu Vaccine in Solid Organ Transplant.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01808456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*